Cargando…
Antisense oligonucleotide eluforsen improves CFTR function in F508del cystic fibrosis
BACKGROUND: Cystic fibrosis (CF) is caused by mutations in the CF transmembrane conductance regulator (CFTR) gene. In this study we assessed the effect of antisense oligonucleotide eluforsen on CFTR biological activity measured by Nasal Potential Difference (NPD) in patients with the most common mut...
Autores principales: | Sermet-Gaudelus, Isabelle, Clancy, John P., Nichols, David P., Nick, Jerry A., De Boeck, Kris, Solomon, George M., Mall, Marcus A., Bolognese, James, Bouisset, Florilene, den Hollander, Wilhelmina, Paquette-Lamontagne, Nicolas, Tomkinson, Nigel, Henig, Noreen, Elborn, J. Stuart, Rowe, Steven M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227803/ https://www.ncbi.nlm.nih.gov/pubmed/30467074 http://dx.doi.org/10.1016/j.jcf.2018.10.015 |
Ejemplares similares
-
Evaluation of eluforsen, a novel RNA oligonucleotide for restoration of CFTR function in in vitro and murine models of p.Phe508del cystic fibrosis
por: Beumer, Wouter, et al.
Publicado: (2019) -
Characterization of Nasal Potential Difference in cftr Knockout and F508del-CFTR Mice
por: Saussereau, Emilie Lyne, et al.
Publicado: (2013) -
Metabolite Profiling of the Antisense Oligonucleotide Eluforsen Using Liquid Chromatography-Mass Spectrometry
por: Kim, Jaeah, et al.
Publicado: (2019) -
An unexpected effect of TNF-α on F508del-CFTR maturation and function
por: Bitam, Sara, et al.
Publicado: (2015) -
Characterization of two rat models of cystic fibrosis—KO and F508del CFTR—Generated by Crispr‐Cas9
por: Dreano, Elise, et al.
Publicado: (2019)